Travere Therapeutics (TVTX) Current Leases (2020 - 2026)
Travere Therapeutics (TVTX) posted Current Leases of $6.0 million for Q1 2026, up 2.42% on a QoQ basis from $5.9 million in Q4 2025, and up 10.2% year-over-year from $5.5 million in Q1 2025.
Travere Therapeutics (TVTX) Current Leases (2020 - 2026) Analysis & Trends
Travere Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $6.0 million for Q1 2026.
- Quarterly Current Leases rose 10.2% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (up 10.2% YoY) and the FY2025 annual result came in at $5.9 million, up 8.7% from the prior year.
- Current Leases was $6.0 million for Q1 2026 at Travere Therapeutics, up from $5.9 million in the prior quarter.
- Across five years, Current Leases topped out at $6.0 million in Q1 2026 and bottomed at $4.0 million in Q1 2022.
- A 5-year average of $5.0 million and a median of $5.0 million in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases climbed 13.43% — and 2025, when it advanced 8.25%.
- Travere Therapeutics' Current Leases stood at $4.4 million in 2022, then advanced by 10.74% to $4.9 million in 2023, then rose by 10.1% to $5.4 million in 2024, then rose by 8.7% to $5.9 million in 2025, then rose by 2.42% to $6.0 million in 2026.
- Business Quant data shows TVTX's Current Leases at $6.0 million in Q1 2026, $5.9 million in Q4 2025, and $5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.02 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | 5.73 Mn |
| Jun 30, 2025 | 5.60 Mn |
| Mar 31, 2025 | 5.46 Mn |
| Dec 31, 2024 | 5.41 Mn |
| Sep 30, 2024 | 5.30 Mn |
| Jun 30, 2024 | 5.16 Mn |
| Mar 31, 2024 | 5.04 Mn |
| Dec 31, 2023 | 4.91 Mn |
| Sep 30, 2023 | 4.78 Mn |
| Jun 30, 2023 | 4.66 Mn |
| Mar 31, 2023 | 4.55 Mn |
| Dec 31, 2022 | 4.43 Mn |
| Sep 30, 2022 | 4.23 Mn |
| Jun 30, 2022 | 4.12 Mn |
| Mar 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 3.91 Mn |
| Dec 31, 2020 | 357,000.00 |